Patents by Inventor Peter Colabuono
Peter Colabuono has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11891386Abstract: The present disclosure relates to indole compounds and pharmaceutical compositions thereof, and their use in stimulating the immune system of patients in need thereof and in treating cancer.Type: GrantFiled: August 15, 2022Date of Patent: February 6, 2024Assignee: ARIAGEN, INC.Inventors: Peter Colabuono, Graham Johnson, David Douglas Manning, Mark Allan Wolf
-
Publication number: 20230145074Abstract: The present disclosure relates to indole compounds and pharmaceutical compositions thereof, and their use in stimulating the immune system of patients in need thereof and in treating cancer.Type: ApplicationFiled: August 15, 2022Publication date: May 11, 2023Applicant: ARIAGEN, INC.Inventors: Peter Colabuono, Graham Johnson, David Douglas Manning, Mark Allan Wolf
-
Publication number: 20230054194Abstract: The present disclosure relates to methods of treating cancer in a patient using a combination of an inhibitor of an immune checkpoint protein and an indole compound or its phosphate derivative.Type: ApplicationFiled: November 19, 2019Publication date: February 23, 2023Applicant: ARIAGEN, INC.Inventor: Peter Colabuono
-
Publication number: 20220389002Abstract: The present disclosure relates to indole compounds and pharmaceutical compositions thereof, and their use in stimulating the immune system of patients in need thereof and in treating cancer.Type: ApplicationFiled: May 18, 2022Publication date: December 8, 2022Applicant: ARIAGEN, INC.Inventors: Graham Johnson, Peter Colabuono, Paul Gerard Pearson, David Douglas Manning
-
Patent number: 11459322Abstract: The present disclosure relates to indole compounds and pharmaceutical compositions thereof, and their use in stimulating the immune system of patients in need thereof and in treating cancer.Type: GrantFiled: November 19, 2018Date of Patent: October 4, 2022Assignee: ARIAGEN, INC.Inventors: Peter Colabuono, Graham Johnson, David Douglas Manning, Mark Allan Wolf
-
Patent number: 11427576Abstract: The present disclosure relates to indole compounds and pharmaceutical compositions thereof, and their use in stimulating the immune system of patients in need thereof and in treating cancer.Type: GrantFiled: February 18, 2021Date of Patent: August 30, 2022Assignee: ARIAGEN, INC.Inventors: Peter Colabuono, Graham Johnson, David Douglas Manning, Mark Allan Wolf
-
Patent number: 11390621Abstract: The present disclosure relates to indole compounds and pharmaceutical compositions thereof, and their use in stimulating the immune system of patients in need thereof and in treating cancer.Type: GrantFiled: February 18, 2021Date of Patent: July 19, 2022Assignee: ARIAGEN, INC.Inventors: Graham Johnson, Peter Colabuono, Paul Gerard Pearson, David Douglas Manning
-
Publication number: 20210188834Abstract: The present disclosure relates to indole compounds and pharmaceutical compositions thereof, and their use in stimulating the immune system of patients in need thereof and in treating cancer.Type: ApplicationFiled: February 18, 2021Publication date: June 24, 2021Applicant: ARIAGEN, INC.Inventors: Graham Johnson, Peter Colabuono, Paul Gerard Pearson, David Douglas Manning
-
Publication number: 20210179604Abstract: The present disclosure relates to indole compounds and pharmaceutical compositions thereof, and their use in stimulating the immune system of patients in need thereof and in treating cancer.Type: ApplicationFiled: February 18, 2021Publication date: June 17, 2021Applicant: ARIAGEN, INC.Inventors: Peter Colabuono, Graham Johnson, David Douglas Manning, Mark Allan Wolf
-
Publication number: 20200354353Abstract: The present disclosure relates to indole compounds and pharmaceutical compositions thereof, and their use in stimulating the immune system of patients in need thereof and in treating cancer.Type: ApplicationFiled: November 19, 2018Publication date: November 12, 2020Applicant: ARIAGEN, INC.Inventors: Peter Colabuono, Graham Johnson, David Douglas Manning, Mark Allan Wolf
-
Patent number: 9968553Abstract: Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.Type: GrantFiled: December 21, 2017Date of Patent: May 15, 2018Assignees: SILVERGATE PHARMACAUTICALS, INC., UNIVERSITY OF KANSASInventors: Lian G. Rajewski, Roger A. Rajewski, John L. Haslam, Kathleen Heppert, Michael C. Beckloff, Frank Segrave, Robert Mauro, Peter Colabuono
-
Publication number: 20180116954Abstract: Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.Type: ApplicationFiled: December 21, 2017Publication date: May 3, 2018Inventors: Lian G. RAJEWSKI, Roger A. RAJEWSKI, John L. HASLAM, Kathleen HEPPERT, Michael C. BECKLOFF, Frank SEGRAVE, Robert MAURO, Peter COLABUONO
-
Patent number: 9855214Abstract: Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.Type: GrantFiled: February 15, 2017Date of Patent: January 2, 2018Assignees: SILVERGATE PHARMACEUTICALS, INC, UNIVERSITY OF KANSASInventors: Lian G. Rajewski, Roger A. Rajewski, John L. Haslam, Kathleen Heppert, Michael C. Beckloff, Frank Segrave, Robert Mauro, Peter Colabuono
-
Publication number: 20170181968Abstract: Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.Type: ApplicationFiled: February 15, 2017Publication date: June 29, 2017Inventors: Lian G. RAJEWSKI, Roger A. RAJEWSKI, John L. HASLAM, Kathleen HEPPERT, Michael C. BECKLOFF, Frank SEGRAVE, Robert MAURO, Peter COLABUONO
-
Publication number: 20150258027Abstract: Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.Type: ApplicationFiled: October 2, 2013Publication date: September 17, 2015Inventors: Lian G. Rajewski, Roger A. Rajewski, John L. Haslam, Kathleen Heppert, Michael C. Beckloff, Frank Segrave, Robert Mauro, Peter Colabuono
-
Patent number: 8778366Abstract: Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.Type: GrantFiled: June 10, 2013Date of Patent: July 15, 2014Assignees: University of Kanasas, Silvergate Pharmaceuticals, Inc.Inventors: Lian G. Rajewski, Roger A. Rajewski, John L. Haslam, Kathleen Heppert, Michael C. Beckloff, Frank Segrave, Robert Mauro, Peter Colabuono
-
Publication number: 20140100260Abstract: Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.Type: ApplicationFiled: June 10, 2013Publication date: April 10, 2014Inventors: Lian G. Rajewski, Roger A. Rajewski, John L. Haslam, Kathleen Heppert, Michael C. Beckloff, Frank Segrave, Robert Mauro, Peter Colabuono
-
Patent number: 8568747Abstract: Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.Type: GrantFiled: November 6, 2012Date of Patent: October 29, 2013Assignees: Silvergate Pharmaceuticals, Inc., University of KansasInventors: Lian G. Rajewski, Roger A. Rajewski, John L. Haslam, Kathleen Heppert, Michael C. Beckloff, Frank Seagrave, Robert Mauro, Peter Colabuono